Viewing Study NCT07090369


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-02 @ 12:46 AM
Study NCT ID: NCT07090369
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-29
First Post: 2025-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module